Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

806 results about "CMC chromatography" patented technology

Process for the preparation of a desired erythropoietin glyco-isoform profile

The present invention provides a process for the production of erythropoietin (EPO) with high purity and with a desired profile of EPO glycol-isoforms by using a combination of specific chromatographic steps in such a manner that the starting EPO glycol-isoform profile is changed or modified. The applied chromatographic steps includes at least (a) dye affinity chromatography, and (b) hydrophobic chromatography and / or (c) anion-exchange chromatography. In a preferred embodiment, the process further includes (d) gel filtration chromatography. The present invention also provides a process for the determination of erythropoietin (EPO) glycol-isoform profile in an EPO containing composition.
Owner:SVETINA MONICA +4

Enhanced purification of antibodies and antibody fragments by apatite chromatography

Methods are disclosed for use of apatite chromatography, particularly without reliance upon phosphate gradients, for purification or separation of at least one intact non-aggregated antibody, or at least one immunoreactive antibody fragment, from an impure preparation. Integration of such methods into multi-step procedures with other fractionation methods are additionally disclosed.
Owner:BIO RAD LAB INC

Apparatus for screening compound libraries

Disclosed are apparatus for screening compound libraries using frontal chromatography in combination with mass spectrometry to identify and rank those members of the library that bind to a target receptor. The apparatus of this invention also permit a compound library to be rapidly screened to determine if any member of the library has a higher affinity for the target receptor relative to a pre-selected indicator compound.
Owner:SYNSORB BIOTECH INC

Retentate chromatography and protein chip arrays with applications in biology and medicine

This invention provides methods of retentate chromatography for resolving analytes in a sample. The methods involve adsorbing the analytes to a substrate under a plurality of different selectivity conditions, and detecting the analytes retained on the substrate by desorption spectrometry. The methods are useful in biology and medicine, including clinical diagnostics and drug discovery.
Owner:BIO RAD LAB INC

Purification of proteins using hydrophobic interaction chromatography

ActiveUS8946395B1Great purification and recovery of proteinGreat purification and recoveryVirus peptidesImmunoglobulins against cytokines/lymphokines/interferonsProtein proteinChemistry
The present invention is directed to methods for purifying a protein of interest, e.g., an antibody, from a sample comprising the protein of interest and at least one impurity, e.g., an aggregate, by employing a hydrophobic interaction chromatography (HIC) method that allows for binding of both the protein of interest and the at least one impurity under strong binding conditions. The present invention is based, at least in part, on the finding that both flow through and bind-elute techniques can be combined to achieve greater purification and recovery of a protein of interest, e.g., an antibody, under isocratic wash conditions and strong binding conditions.
Owner:ABBVIE INC

Process for producing immunoglobulins for intravenous administration and other immunoglobulin products

InactiveUS7138120B2Improve administeringAdminister intravenouslySerum immunoglobulinsAntiviralsChemistryIntrathecal
The present invention relates to a process for purifying immunoglobulin G from a crude immunoglobulin-containing plasma protein fraction. Said process includes a number of steps of which the anion exchange chromatography and the cation exchange chromatography are preferably connected in series. An acetate buffer having a pH of about 5.0-6.0 and having a molarity of about 5-25 mM is preferably used throughout the purification process. The invention further comprises an immunoglobulin product which is obtainable by this process. The invention also relates to an immunoglobulin product which has a purity of more than 98%, has a content of IgG monomers and dimers of more than 98.5%, has a content of IgA less than 4 mg of IgA / l, and contains less than 0.5% polymers and aggregates. Said product does not comprise detergent, PEG or albumin as a stabilizer. The product is stable, virus-safe, liquid and ready for instant intravenous administration.
Owner:CSL BEHRING AG

Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof

A high temperature-stable and highly purified cross-linked (optionally ≧70% β-β linked) tetrameric hemoglobin with high efficiency of oxygen delivery suitable for use in mammals without causing renal injury and vasoconstriction is provided. The dimeric form of hemoglobin is degenerated and purification processes are performed on red blood cells from whole blood. Controlled hypotonic lysis in an instant cytolysis apparatus prevents lysis of white blood cells. Nucleic acids from white blood cells and phospholipids impurities are not detected. Blocking of reactive sulfhydryl groups by a sulfhydryl reagent is performed in an oxygenated environment. Flowthrough column chromatography removes different plasma protein impurities. N-acetyl cysteine is added to the cross-linked tetrameric hemoglobin to maintain a low level of met-hemoglobin. The stabilized hemoglobin is preserved in an infusion bag with aluminum overwrap to prevent formation of inactive met-hemoglobin from oxygen intrusion. The product finds use in tissue oxygenation and cancer treatment.
Owner:BILLION KING INT

Hydroxyl carthamus tinctorius yellow colour A, preparation method and application thereof

The invention relates to a hydroxysaffloryellow A extracted from Chinese medicinal material safflower, a relative preparation method and application thereof. The inventive extraction method of hydroxysaffloryellow A is stuffed into chromatography column according to different diameter-height ratios, the invention uses the upper sample to process column chromatography according to different ratios between upper sample volumes and bed volumes, to separate and purify safflower extract. The invention has simple process, few steps, low cost, high yield, no environment pollution and suitability for industrialized and large-scale production. The yield of extracted hydroxysaffloryellow A is higher than 50%, while the hydroxysaffloryellow A content tested by high-effect liquid hydroxysaffloryellow A reaches 99.5%. The drug prepared from the hydroxysaffloryellow A can effectively prevent and treat cerebrovascular diseases as cerebral infraction and hypertensive cerebral hemorrhage or the like.
Owner:山西德元堂药业有限公司

Control System For Simulated Moving Bed Chromatography

The present invention provides devices and methods for micro-scale simulated moving bed chromatography (SMB) for continuous preparation of analytic quantities of highly pure fractions of target molecules. The present apparatus and method of the invention is adapted in a preferred embodiment to separations by affinity chromatography involving three discontinuous liquid flow loops. An alternative embodiment of affinity chromatography utilizes standard SMB operating under isocratic conditions.
Owner:TOSOH BIOSCIENCE LLC

Liquid chromatography for synchronously detecting 15 anabolic hormone residues in food

The invention relates to a liquid chromatography for detecting anabolic hormone drug residue in animal-derived food, which is characterized by first sampling: animal musculature is taken off the fat and connective tissue, then minced and evenly ground, and the sample is weighed; extracting: anabolic hormone extract is extracted from the weighed sample by methanol ultrasonic extraction, the extract is evaporated to dryness in water bath through a rotary evaporator, and the residue is dissolved by methanol aqueous solution; purifying: C18 Solidoid extraction column on the extract is carried out solid phase extraction; and testing by devices: the filtrate is tested by opposite phase high efficiency liquid chromatography, quantified by external reference method-peak area, and then carried out with binary gradient elution. In the invention, the detected sample is complex biological sample; the established method can complete one detection in about one hour and is simple and fast, with reliable sensitivity and low cost; the method can analyze more veterinary hormone drug species than the synchronous usage of the existing GC or HPLC methods with easier operation, and has lower cost than the existing GC / MS and LC / MS or LC / MS / MS methods with low solvent toxicity.
Owner:上海国矗生物科技有限公司

Separation of fibrinogen from plasma proteases

The present invention relates to methods for purifying fibrinogen. In one aspect, the present invention relates to a method of separating fibrinogen from plasma fraction I precipitate. In another aspect, the invention relates to the purification of fibrinogen using ion exchange chromatography.
Owner:CSL LTD

Continuous Isocratic Affinity Chromatography

The present invention provides devices and methods for micro-scale simulated moving bed chromatography (SMB) for continuous preparation of analytic quantities of highly pure fractions of target molecules. The present apparatus and method of the invention is adapted in a preferred embodiment to separations by affinity chromatography involving three discontinuous liquid flow loops. An alternative embodiment of affinity chromatography utilizes standard SMB operating under isocratic conditions.
Owner:TOSOH BIOSCIENCE LLC

Method For The Removal Of Aggregate Proteins From Recombinant Samples Using Ion Exchange Chromatography

The present invention relates to processes for the removal of unwanted protein aggregates from antibody preparations. One process involves removal when the aggregate and antibody are very close in pI value (“Bind-Elute” process). Another process involves the removal when the aggregate and antibody are very close in net electric charge and retention time on ion exchange resin (“Bind-Washout” process). Using either process, at least 90% of the antibody is recovered and 70-90% of the aggregate is removed.
Owner:GENENTECH INC

Method for orthogonal analyte stacking/injection systems in electrophoresis

InactiveUS7223325B2High resolutionFaster and high injectionSludge treatmentVolume/mass flow measurementCapillary volumePresent method
In the present capillary electrokinetic chromatograpy method, analytes are injected by electroosmotic flow directly from a sample matrix into a separation buffer containing an electrokinetic vector with an opposite mobility. Analytes can now be injected at the velocity of electroosmotic flow, but are retained at the interface of the sample matrix-co-ion and separation buffer micelle zones as analyte / micelle complexes. Manipulation of the injecting force and opposing stacking force allow greatly increased length or volume of injection. Concentrations of the micelle, methanol, and borate in the separation buffer were provided to increase maximum injection length of neutral analytes. Reducing the analyte velocity in the separation buffer without substantially decreasing the velocity of the analyte during injection from the sample vial allowed greatly extended sample plug injection lengths. It is further enabled to inject sample solvent volumes equivalent to about twenty times the effective capillary volume. Equations and algorithms describing the injection process and maximum injection lengths for this mode of stacking in electrokinetic capillary chromatography are introduced. Use of the present method provides for maximum electrokinetic stacking injection for a wide variety of analytes and separation systems.
Owner:UNIV OF VIRGINIA ALUMNI PATENTS FOUND

Reagents and methods for performing electrokinetic chromatography

The invention is in the field of electrokinetic chromatography. In particular, the invention is directed to reagents and methods of performing electrokinetic chromatography. The reagents and methods afford fast, high resolution separations with increased detectability.
Owner:WATERS TECH CORP

Yellow pigment of safflower preparation method and application

This invention provides safflower uranidin prepd. from the Chinese herb medicine-safflower which isu sed for promoting blood circulation and removing blood disturbance, and the prepn. method and usage therefor. Said safflower uranidin is tested by high efficiency liquid phase chromatography with its content of 70-99.6%. It can be used for treating and preventing various kinds of diseases, such as cardiovascular disease, cerebrovascular disease and other blood circulation disturbance disease.
Owner:ZHEJIANG YONGNING PHARMA

Taurolidine quality checking method

The invention provides a quality detection method for Taurolidine. The method uses thin-layer chromatography, gas phase chromatography and titering process to detect the quality of the Taurolidiene. The quality detection method for Taurolidine has the advantages of rapidness, accuracy, convenient operation and excellent reproduction quality, and ensures the product quality of the Taurolidine.
Owner:CHANGCHUN MAILING BIOLOGICAL ENG CO LTD

Purification of recommbined human urokinase zymogen

The invention is about a method to purify the recombined human urokinase by the chromatography. The invention relates to recovery the gene engineering production from the mammal cell culture using the Streamline-SP, Sephacryl S-200, Sepharose Fast Flow and DEAE-Sepharose Fast Flow method. The recombined human urokinase can meet the SFDA standard and the percent recovery is above 70%, the purity is above 99% by using the method.
Owner:TASLY BIOPHARMACEUTICALS CO LTD

Coumarin compounds, and preparation method and application thereof

The invention discloses coumarin compounds. The preparation method comprises the following steps: extracting from rattan of Derris eriocarpa How by the inventor; according to the detection introduction of thin-layer chromatography, carrying out reversed-phase silica gel column chromatography, carrying out gradient elution by a petroleum ether-ethyl acetate system for further systematic separation, and recrystallizing. The antioxidation activity experiment proves that the compounds 1 have favorable antioxidation actions, the IC50 value for superoxide anion removal activity is less than that of the positive drug control ascorbic acid, the IC50 value DPPH.free radical removal activity has no great difference from the positive drug, and the compounds 1 have excellent antioxidation activity as compared with the coumarin compounds 6,7-dihydroxycoumarin, daphnetin and daphnoretin which are reported in documents. Therefore, the coumarin compounds disclosed by the invention can be used as a pharmaceutical or non-pharmaceutical antioxidant and the like.
Owner:GUANGXI UNIV FOR NATITIES

Multiple-channel test device, method for producing the same and use thereof

The object of the invention is a multiple-channel test devise based on immunodiffusion and immunochromatography, which enables the simultaneous or parallel determination of several analytes. In the test devise, it is possible to group together different combinations of markers recognizing allergens, myocardial infarction markers, venereal disease analytes, blood screening analytes, respiratory infection producing agents, IgG, IgA and IgM antibodies, other infectious disease producing agents as well as various cancer markers. The multiple-channel test devise comprises a porous carrier material on which a channel network has been formed by etching the carrier material by laser to form a shaped figure that contains several channels. In the channels, various specific binding reagents have been immobilized, which enable the diagnoses of a target illness and / or syndrome. The sample application point is optionally provided with a filter and optionally contains a label mobilizable by the analyzable sample and a specific binding reagent. Also the method for the production of the test device and its use are disclosed in the invention.
Owner:ANI BIOTECH

Valve module and methods for simulated moving bed chromatography

The present invention provides devices and methods for micro-scale simulated moving bed chromatography (SMB) for continuous preparation of analytic quantities of highly pure fractions of target molecules. The present apparatus and method of the invention is adapted in a preferred embodiment to separations by affinity chromatography involving three discontinuous liquid flow loops. An alternative embodiment of affinity chromatography utilizes standard SMB operating under isocratic conditions.
Owner:TOSOH BIOSCIENCE LLC

Quality testing method for fingerprint of herbal medicine musk

The invention discloses a quality testing method for fingerprint of herbal medicine musk. The method includes establishing a gas chromatographic fingerprint of the musk by gas chromatography, and analyzing chemical components of different types of musk by gas chromatography and mass spectrometry. A test sample is processed by specific process, chromatographic detection is optimized, and tests show that the method is stable, precise and repeatable. Three established reference musk fingerprints are well specific. Similarity of the three types of musk is researched under integration of non-integration conditions of muscone, and more accurate basis is provided for testing quality of the three different types of musk. In addition, common compounds of the three types of musk are obtained by identification by GC-MS (gas chromatography and mass spectrometry) and can be used as basis for further identification of synthetic musk, domestic musk and natural musk.
Owner:ZHANGZHOU PIEN TZE HUANG PHARM

Medicine for treating infantile anorexia, its preparing method and quality control method

A Chinese medicine for treating anorexia of baby is prepared from 12 Chinese-medicinal materials including tuckahoe, tangerine peel, haw, rhubarb, etc through decocting, filtering, concentrating, mixing, etc. Its quality control method including thin-layer chromatography and high-effect liquid-phase chromatography is also disclosed.
Owner:GUANGDONG ZHONGSHENG PHARMA

Walnut peptide having ACE inhibitory activity and preparation method thereof

The invention discloses walnut peptide having the ACE inhibitory activity and a preparation method thereof. The amino acid sequence of the walnut peptide is EPNGLLLPGY, and the preparation method of the walnut peptide comprises the steps of taking walnut pomace as raw materials, selecting appropriate protease, preparing walnut antihypertensive peptide coarse products according to the optimal enzymolysis technology, adopting the coupling chromatographic technique of the membrane technology for conducting fine preparation on the walnut antihypertensive peptide, adopting the high performance liquid chromatography for conducting further purification, and adopting the vacuum freeze drying or low-temperature spray drying technology for preparing final products. According to the walnut peptide, the walnut pomace is adopted as the raw materials for developing the protein peptide, the raw materials are abundant, the price is low, and the large-scale industrialized production can be satisfied; the walnut peptide has important significance in walnut protein product diversification and development and utlization of walnut biological active peptide in functional foodstuff, health food or medicine.
Owner:HARBIN INST OF TECH

Preparing method of human serum albumin

The invention relates to the technical field of biological product and blood product production, and mainly relates to a separation and purification method of human serum albumin in the blood product production, in particular to a preparing method of human serum albumin. According to the method, healthy plasma supernatant is used as raw materials; a Kistler-Nitchmann low-temperature ethanol method is adopted for precipitating and separating ingredients FI+II+III and ingredients FIV; supernatant after the ingredient FIV separation is subjected to dealcoholization treatment; then, one-step ion exchange chromatography and ultrafiltration are further performed; a proper amount of sodium caprylate is added as a stabilizer; after the Pasteur virus inactivation treatment is performed, the human serum albumin finished product is obtained. Through efficient liquid chromatography detection, the purity of the human serum albumin prepared by the process is higher than 99 percent; the polymer content is lower than or equal to 1 percent; the yield of the plasma reaches 28 to 30g / L. The purity of the product is higher; the impurity protein content is lower, so that the clinical medication is safer.
Owner:SHANDONG TAIBANG BIOLOGICAL PROD CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products